Chong Kun Dang Pharmaceutical Corp. (185750.KS)
185750.KS Stock Price Chart
Explore Chong Kun Dang Pharmaceutical Corp. interactive price chart. Choose custom timeframes to analyze 185750.KS price movements and trends.
185750.KS Company Profile
Discover essential business fundamentals and corporate details for Chong Kun Dang Pharmaceutical Corp. (185750.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
6 Dec 2013
Employees
2.28K
Website
https://www.ckdpharm.comCEO
Young-Joo Kim
Description
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
185750.KS Financial Timeline
Browse a chronological timeline of Chong Kun Dang Pharmaceutical Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 1 Aug 2025
Earnings released on 15 May 2025
EPS came in at ₩894.00 falling short of the estimated ₩1.72K by -47.89%, while revenue for the quarter reached ₩400.96B , missing expectations by -4.97%.
Earnings released on 4 Feb 2025
EPS came in at ₩659.50 falling short of the estimated ₩1.23K by -46.57%, while revenue for the quarter reached ₩415.36B , beating expectations by +1.50%.
Dividend declared on 27 Dec 2024
A dividend of ₩1.05K per share was announced, adjusted to ₩1.05K. The dividend was paid on 1 Apr 2025.
Stock split effective on 27 Dec 2024
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 25 Oct 2024
EPS came in at ₩1.73K surpassing the estimated ₩1.49K by +16.00%, while revenue for the quarter reached ₩412.76B , beating expectations by +0.90%.
Earnings released on 26 Jul 2024
EPS came in at ₩4.21K surpassing the estimated ₩1.90K by +121.83%, while revenue for the quarter reached ₩396.80B , beating expectations by +2.90%.
Earnings released on 26 Apr 2024
EPS came in at ₩2.01K surpassing the estimated ₩1.72K by +16.91%, while revenue for the quarter reached ₩353.45B , missing expectations by -0.20%.
Earnings released on 5 Feb 2024
EPS came in at ₩6.94K surpassing the estimated ₩1.18K by +488.16%, while revenue for the quarter reached ₩504.61B , beating expectations by +0.66%.
Dividend declared on 27 Dec 2023
A dividend of ₩1.10K per share was announced, adjusted to ₩1.05K. The dividend was paid on 5 Apr 2024.
Stock split effective on 27 Dec 2023
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Oct 2023
EPS came in at ₩3.76K surpassing the estimated ₩2.30K by +63.44%, while revenue for the quarter reached ₩403.61B , beating expectations by +1.60%.
Earnings released on 28 Jul 2023
EPS came in at ₩3.52K surpassing the estimated ₩2.07K by +70.45%, while revenue for the quarter reached ₩396.01B , beating expectations by +2.68%.
Earnings released on 28 Apr 2023
EPS came in at ₩2.95K surpassing the estimated ₩1.60K by +84.53%, while revenue for the quarter reached ₩365.18B , beating expectations by +0.58%.
Earnings released on 3 Feb 2023
EPS came in at ₩1.02K falling short of the estimated ₩1.18K by -13.30%, while revenue for the quarter reached ₩397.06B , beating expectations by +3.81%.
Dividend declared on 28 Dec 2022
A dividend of ₩1.05K per share was announced, adjusted to ₩952.38. The dividend was paid on 7 Apr 2023.
Stock split effective on 28 Dec 2022
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Oct 2022
EPS came in at ₩2.34K surpassing the estimated ₩2.04K by +14.55%, while revenue for the quarter reached ₩383.89B , beating expectations by +1.37%.
Earnings released on 16 Aug 2022
EPS came in at ₩1.88K surpassing the estimated ₩1.81K by +3.95%, while revenue for the quarter reached ₩366.03B , beating expectations by +1.31%.
Earnings released on 29 Apr 2022
EPS came in at ₩1.41K falling short of the estimated ₩1.55K by -8.82%, while revenue for the quarter reached ₩341.37B , beating expectations by +0.31%.
Earnings released on 10 Feb 2022
EPS came in at ₩137.14 falling short of the estimated ₩1.11K by -87.69%, while revenue for the quarter reached ₩361.87B , beating expectations by +3.96%.
Dividend declared on 29 Dec 2021
A dividend of ₩1.00K per share was announced, adjusted to ₩907.03. The dividend was paid on 8 Apr 2022.
Stock split effective on 29 Dec 2021
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Oct 2021
EPS came in at ₩172.34 falling short of the estimated ₩1.94K by -91.11%, while revenue for the quarter reached ₩342.24B .
Earnings released on 17 Aug 2021
EPS came in at ₩1.92K falling short of the estimated ₩2.03K by -5.19%, while revenue for the quarter reached ₩327.54B .
Earnings released on 30 Apr 2021
EPS came in at ₩1.20K falling short of the estimated ₩1.68K by -28.53%, while revenue for the quarter reached ₩311.91B .
Earnings released on 18 Mar 2021
EPS came in at ₩1.26K surpassing the estimated ₩912.19 by +38.03%, while revenue for the quarter reached ₩337.23B .
Dividend declared on 29 Dec 2020
A dividend of ₩952.38 per share was announced, adjusted to ₩822.70. The dividend was paid on 9 Apr 2021.
Stock split effective on 29 Dec 2020
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Oct 2020
EPS came in at ₩2.93K surpassing the estimated ₩1.62K by +80.54%, while revenue for the quarter reached ₩358.39B .
185750.KS Stock Performance
Access detailed 185750.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.